Picture of Carna Biosciences logo

4572 — Carna Biosciences News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Table: Garna Biosciences - 9-MTH group results

Nov 8 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2019        Sep 30, 2018     Dec 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               2.86               586 mln           3.04     
                  (+387.7 pct)         (+21.4 pct)     (+302.6 pct) 
  Operating           1.36            loss 762 mln        313 mln   
  Recurring           1.35            loss 773 mln        279 mln   
  Net                 1.11            loss 822 mln        214 mln   
  EPS              104.16 yen        loss 85.82 yen      20.12 yen  
  EPS Diluted      102.07 yen                                       
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T

Recent news on Carna Biosciences

See all news